Japan Tobacco launches 'With 2 Special Edition' HTP device, priced from $26

Nov.06.2024
Japan Tobacco launches 'With 2 Special Edition' HTP device, priced from $26
Japan Tobacco (JT) to launch "With 2 Special Edition" HTP device on November 5, priced at ¥3980 ($26).

On November 5th, Japan Tobacco (JT) announced on its official website that it will be releasing a special edition of its heated tobacco device, "With 2 Special Edition," starting from November 5th. The device will be sold for 3,980 yen (26 US dollars).

 

This limited edition model maintains the taste, basic performance, and size of the original "With 2," and will be available in two colors: silver and dark gray.

 

Japan Tobacco launches 'With 2 Special Edition' HTP device, priced from $26
Translation: With 2 Special Editions | Image source: clubjt

 

Japan Tobacco launches 'With 2 Special Edition' HTP device, priced from $26
With 2 special editions | Image source: clubjt

 

 

Japan Tobacco launches 'With 2 Special Edition' HTP device, priced from $26
With 2 special editions | Image source: clubjt

 

The "With 2 Special Edition" is available for purchase on the CLUB JT online store and is compatible with five different brands of tobacco capsules.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Global Tobacco Oversupply and Climate Risks Highlighted at ITGA Annual Meeting
Global Tobacco Oversupply and Climate Risks Highlighted at ITGA Annual Meeting
In 2025, global tobacco leaf production surged, but prices stagnated as climate change intensified farming risks. 2Firsts reports from the ITGA meeting, revealing structural challenges and transition pressures in the industry.
Sep.29
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore will classify the anesthetic etomidate as a Class C drug from September 1, with traffickers and users facing prosecution and a minimum one-year jail term. The move comes amid growing concerns over the health risks posed by etomidate-laced e-cigarettes, which have become increasingly popular. The government has stepped up enforcement efforts, seizing over 850 e-cigarettes in recent operations.
Aug.25 by 2FIRSTS.ai
Company | BAT: glo Hilo Series to Expand to Italy, Poland and Serbia
Company | BAT: glo Hilo Series to Expand to Italy, Poland and Serbia
Recently, British American Tobacco (BAT) announced on social media that it has officially launched the glo™ Hilo product line nationwide in Japan, including the new glo™ Hilo, glo™ Hilo Plus, and virto™ heated sticks. BAT said the series will soon expand to Italy, Poland, and Serbia. The company aims to reach 50 million adult consumers of smokeless products by 2030 and to become a predominantly smokeless business by 2035.
Sep.12 by 2FIRSTS.ai
A former Singapore Health and Science Agency (HSSA) authorized enforcement officer has been charged with leaking e-cigarette enforcement intelligence in a bribery case
A former Singapore Health and Science Agency (HSSA) authorized enforcement officer has been charged with leaking e-cigarette enforcement intelligence in a bribery case
A former e-cigarette enforcement chief in Singapore has been charged with accepting a S$8,000 (US$6,200) bribe after repeatedly providing intelligence to a man involved in an upcoming Health Sciences Authority (HSA) e-cigarette crackdown in 2024.
Sep.05 by 2FIRSTS.ai
Minnesota Teacher Charged with Sharing Marijuana Vape with Students During Utah Field Trip
Minnesota Teacher Charged with Sharing Marijuana Vape with Students During Utah Field Trip
A Minnesota teacher has been charged with three counts of drug distribution for allegedly providing a marijuana vape to underage students during a field trip in Utah.
Aug.21 by 2FIRSTS.ai
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
The US Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) for Imperial Tobacco’s blu® Disposable Classic Tobacco 2.4% e-cigarette, prohibiting its sale and distribution in the United States. FDA’s review found that the company’s Premarket Tobacco Product Application (PMTA) did not provide sufficient evidence to demonstrate that the product could help smokers fully switch to e-cigarettes or significantly reduce cigarette consumption. Instead, existing evidence suggested
Aug.20 by 2FIRSTS.ai